| Structure | Chemical Name | CAS | MF |
|
EP-204
|
|
|
|
EP-045
|
83648-59-3
|
C22H29N3O3
|
|
EP-171
|
122089-44-5
|
C23H29FO5
|
|
|
EP-169
|
|
|
|
EP 045
|
82597-51-1
|
C22H29N3O3
|
|
|
Enriched boric acid in water with 10B amount fraction of 31.
|
|
|
|
|
Enriched boric acid in water with 10B amount fraction of 29.
|
|
|
|
|
Enriched boric acid in water with 10B amount fraction of 49.
|
|
|
|
|
Enriched boric acid in water with 10B amount fraction of 21.
|
|
|
|
|
ENRICHEDSELENIUMYEAST
|
|
|
|
|
ENRICHEDSELENIUMPOLYSACCHAROSE
|
|
|
|
|
EnrichedTritium
|
|
|
|
|
ENRICHED THIOGLYCOLLATE BROTH
|
|
|
|
|
Enriched Thioglycollate Medium,Base (Thioglycollate Medium, Enriched)
|
|
|
|
Ensaculin
|
155773-59-4
|
C26H32N2O5
|
|
(E)-N-[(S)-1-Benzyl-2-hydroxyethyl]-2-butenamide
|
|
C13H17NO2
|
|
(E)-N-[(S)-1-Benzyl-2-hydroxyethyl]-2-hexenamide
|
|
C15H21NO2
|
|
(E)-N-[(S)-1-Benzyl-2-hydroxyethyl]-5-benzyloxy-2-pentenamide
|
|
C21H25NO3
|
|
(E)-N-[(S)-1-Benzyl-2-hydroxyethyl]-3-(2-furanyl)acrylamide
|
|
C16H17NO3
|
|
(E)-N-[(S)-1-Benzyl-2-hydroxyethyl]-4-benzyloxy-2-butenamide
|
|
C20H23NO3
|
|
(E)-N-[(S)-1-Benzyl-2-hydroxyethyl]-4-bromo-2-butenamide
|
|
C13H16BrNO2
|
|
(E)-2-[N-[(2S)-2,3-Dihydroxy-1-oxopropyl]glycylamino]-N-[(3R)-2-oxo-1-sulfo-3-azetidinyl]-2-butenediamide
|
108065-96-9
|
C12H17N5O10S
|
|
(E)-2-[N-[(2S)-2,3-Dihydroxy-1-oxopropyl]-D-serylamino]-N-[(3R)-2-oxo-1-sulfo-3-azetidinyl]-2-butenediamide
|
108065-95-8
|
|
|
(E)-2-[[N-[(2S)-2,3-Dihydroxy-1-oxopropyl]-D-alanyl]amino]-N-[(3R)-2-oxo-1-sulfo-3-azetidinyl]-2-butenediamide
|
108065-94-7
|
|
|
(E)-N-(SEC-BUTYL)-3-(4-[(2,4-DICHLOROBENZYL)OXY]PHENYL)-2-PROPENAMIDE
|
477888-87-2
|
C20H21Cl2NO2
|
|
|
Enrofloxacin Related Compound Mixture (50 mg)
|
|
|
|
|
Enrofloxacin-d5 hydrochloride VETRANAL
|
|
|
|
|
Enrofloxcin VETRANAL
|
|
|
|
|
Enrofloxacine-D5 hydrochloride
|
|
|
|
|
ENROFLOXACIN SODIUM LACTATE
|
|
|
|
|
EnrofloxacinBase99%Min(Non-Sterile)
|
|
|
|
|
EnrofloxacinInjection
|
|
|
|
|
Enrofloxacin HCL/base
|
|
|
|
|
EnrofloxacinHcl99%Min
|
|
|
|
|
EnrofloxacineBase/Hcl
|
|
|
|
|
Enrofloxacin/Ciprofloxacin
|
|
|
|
|
EnrofloxacinSolutionForOral
|
|
|
|
|
ENROFLOXACINRECRYSTALLINED
|
|
|
|
|
ENROFLOXACIN(ALKALESCENT) SOLUBLE POWDER
|
|
|
|
|
Enrofloxacin nicotinate
|
|
|
|
|
ENROFLOXACIN SOLUBLE POWDER
|
|
|
|
ENROFLOXAIN HYDROCHLORIDE
|
93106-59-3
|
C19H23ClFN3O3
|
|
|
EnrofloxacinInjection2.5%,10%,20%
|
|
|
|
Enrofloxacin
|
93106-60-6
|
C19H22FN3O3
|
|
Enrofloxacin hydrochloride
|
112732-17-9
|
C19H23ClFN3O3
|
|
Enrofloxacin-d5
|
1173021-92-5
|
C19H17D5FN3O3
|
|
Enrofloxacin Sodium
|
266346-15-0
|
C19H21FN3O3.Na
|
|
|
Enrofloxacin HCL/Base/sodium
|
|
|
|
|
Enrofloxacin/Hydrochride
|
|
|
|
ENROFLOXACIN LACTATE
|
931066-01-2
|
C15H16ClN3O2
|
|
|
ENSG 3C protocol
|
|
|
|
(3E)-N-[(2S)-2-Formyl-1-Propylbutyl]Pent-3-Enamide
|
|
C13H23NO2
|
|
|
Enr2 protein
|
|
|
|
(E)-N-((1R,2R)-1-hydroxy-1-phenylpropan-2-yl)-N-methylbut-2-enamide
|
|
C14H19NO2
|
|
ENT 23,970
|
2921-31-5
|
C8H14ClO2PS
|
|
ENT 25,594
|
18722-80-0
|
|
|
(E)-N-[(S)-2-Hydroxy-1-phenylethyl]-2-butenamide
|
|
C12H15NO2
|
|
|
ENSISMACHA
|
|
|
|
|
ent-Abietic acid
|
|
|
|
|
entacapone/carbidopa+entacapone+levodopa
|
|
|
|
|
ENTACTIN,NIDOGEN,CLONE:ELM1,RATMABANTI-GUINEAPIG,MOUSE,NOXW/HUMAN:FROZEN/PARAFFIN,IH
|
|
|
|
|
ENTACTIN(NIDOGEN-1),CLONE:1H12,MABANTI-HUMAN:FROZEN/PARAFFIN,IHC
|
|
|
|
ENTACAPONE-D10
|
1185241-19-3
|
C14H5D10N3O5
|
|
Entacapone
|
116314-67-1
|
|
|
|
Entacapone5-NitroVanilline
|
|
|
|
Entacapone
|
130929-57-6
|
C14H15N3O5
|
|
Entacapone 3-b-D-Glucuronide
|
158069-75-1
|
C20H23N3O11
|
|
|
entactin-2
|
|
|
|
|
Entacapone
|
|
|
|
|
entactin
|
|
|
|
|
ENTADAE STEM PLANT EXTRACT
|
|
|
|
entadamide A
|
100477-88-1
|
C6H11NO2S
|
|
entadamide B
|
110225-60-0
|
C7H15NO2S2
|
|
|
ENTADA PHASEOLOIDES EXTRACT
|
|
|
|
|
ENTADA PHASEOLOIDES LEAF EXTRACT
|
|
|
|
Entagenic acid
|
5951-41-7
|
C30H48O5
|
|
ent-[Amyloid β-Protein (20-16)]-β-Ala-D-Lys(ent-[Amyloid β-Protein (16-20)])
|
1426174-31-3
|
C79H119N15O13
|
|
|
ent-Amyloid b-Protein (1-42)
|
|
|
|
|
EntamoebaHistolytica
|
|
|
|
Entamizole
|
68437-32-1
|
C15H18Cl2N4O5
|
|
|
ENT-AMYLOID BETA-PROTEIN (1-42)
|
342896-25-7
|
|
|
|
EntamoebaHistolyticaHk-9
|
|
|
|
ent-3β-Angeloyloxykaur-16-en-19-oic acid
|
74635-61-3
|
C25H36O4
|
|
|
ENTANDOPHRAGMACYLINDRICUM
|
|
|
|
Entandrophragmin
|
11013-05-1
|
C43H56O17
|
|
ent-16beta,17-Dihydroxy-19-kauraic acid
|
3301-61-9
|
C20H32O4
|
|
ent-16beta,17-Isopropylidenedioxykaurane
|
58493-71-3
|
C23H38O2
|
|
ent-Benazepril-d5
|
|
C24H28N2O5
|
|
|
ent-3 beta-hydroxy-13-epi-manoyl oxide
|
|
|
|
ent-Aprepitant
|
172822-29-6
|
C23H21F7N4O3
|
|
ENT ATOMOXETINE-D3, HYDROCHLORIDE
|
1217703-95-1
|
C17H22ClNO
|
|
ent-Calindol Hydrochloride
|
728930-30-1
|
C21H20ClN2
|
|
ent-Calindol-13C,d2 Hydrochloride
|
1217619-32-3
|
C21H20ClN2
|
|
ent-Calindol Amide-13C
|
1217724-96-3
|
C21H17N2O
|
|
ent-Calindol Amide
|
1217835-51-2
|
C21H18N2O
|
|
|
ENT-CAPALOL, [15-3H]
|
|
|
|
(E)-N-[2-[2-[(2S)-1-methyl-2-piperidyl]ethyl]phenyl]-3-phenyl-prop-2-e namide
|
58754-46-4
|
C23H28N2O
|
|
(+)-ent-Chromazonarol
|
57457-77-9
|
C21H30O2
|
|
ent-Cinacalcet Hydrochloride
|
694495-47-1
|
C22H22F3N
|
|
ent-3β-CinnaMoyloxykaur-16-en-19-oic acid
|
79406-10-3
|
C29H36O4
|